|
Market Cap (5-Jun) $18,417,672 (949th) |
Close (30-Jun) $0.005 |
Volume (30-Jun) 14,697,042 |
Shortsold (2-Apr) 218 (0.00%) (630th) |
|
52w High $9.00 |
52w Low $0.300 |
P/E 14.90 |
EPS -3.21 |
MXC released this announcement to the ASX on 7 December 2022, 15:24. The announcement is marked as price sensitive, and is 3 page(s) in length and 224.62kb in size.
You can view all announcements from MXC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MXC was 0.029% short sold according to ASIC data. It was ranked the 569th most shorted stock on the ASX. It remains ranked 630th as of the latest reported data (02 April 2024).
| Other Recent Announcements from MXC | |
|---|---|
| Details of Company Address | 30 June 2023, 17:34 |
| Company Update | 30 June 2023, 17:24 |
| Results of Meeting | 29 June 2023, 18:43 |
| Completion of CimetrA Efficacy Pre-clinical Trial | 7 December 2022, 15:24 |
| US$1,000,000 ArtemiC order delivered to US partner, AMC | 5 December 2022, 8:20 |
| Publication of Peer Reviewed Glioblastoma Research | 2 December 2022, 17:33 |
| Results of Meeting | 25 November 2022, 10:23 |
You must be logged in to post a reply.
MGC Pharmaceuticals 